Teresa H. Evering

Infectious Disease

156 William St Fl 6
New York, NY 10038

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 study.

Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 study.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios and 10-Year Cardiovascular Risk in HIV.

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios and 10-Year Cardiovascular Risk in HIV.

Journal: medRxiv : the preprint server for health sciences

Published: December 03, 2025

Association of long COVID with health-related quality-of-life outcomes.

Association of long COVID with health-related quality-of-life outcomes.

Journal: Scientific reports

Published: August 12, 2025

Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19.

Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19.

Journal: Pathogens & immunity

Published: January 31, 2025

Transcriptional signature of induced neurons differentiates virologically suppressed people with HIV from people without HIV.

Transcriptional signature of induced neurons differentiates virologically suppressed people with HIV from people without HIV.

Journal: JCI insight

Published: December 18, 2024

A Transcriptional Signature of Induced Neurons Differentiates Virologically Suppressed People Living With HIV from People Without HIV.

A Transcriptional Signature of Induced Neurons Differentiates Virologically Suppressed People Living With HIV from People Without HIV.

Journal: bioRxiv : the preprint server for biology

Published: November 01, 2024

SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19.

SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: May 22, 2024

Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.

Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.

Journal: The Journal of infectious diseases

Published: May 16, 2024

The impact of aging on HIV-1-related neurocognitive impairment.

The impact of aging on HIV-1-related neurocognitive impairment.

Journal: Ageing research reviews

Published: April 02, 2024

Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2.

Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2.

Journal: The Journal of infectious diseases

Published: March 15, 2024

Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiative.

Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiative.

Journal: Journal of clinical and translational science

Published: January 29, 2024

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.

Journal: EClinicalMedicine

Published: December 14, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026